XML 40 R6.htm IDEA: XBRL DOCUMENT  v2.3.0.11
DESCRIPTION OF BUSINESS
6 Months Ended
Jun. 30, 2011
DESCRIPTION OF BUSINESS  
DESCRIPTION OF BUSINESS

1.     DESCRIPTION OF BUSINESS

  • On September 28, 2010 (the "Merger Date"), Biovail Corporation ("Biovail") completed the acquisition of Valeant Pharmaceuticals International ("Valeant") through a wholly-owned subsidiary pursuant to an Agreement and Plan of Merger, dated as of June 20, 2010, with Valeant surviving as a wholly-owned subsidiary of Biovail (the "Merger"). In connection with the Merger, Biovail was renamed "Valeant Pharmaceuticals International, Inc." (the "Company"). The Company is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.